Immunoproteomics: Current technology and applications

  1. Get@NRC: Immunoproteomics: Current technology and applications (Opens in a new window)
DOIResolve DOI:
AuthorSearch for: ; Search for:
Journal titleMethods in Molecular Biology
Pages2157; # of pages: 37
Subjectantigen; biological marker; cytokine; epitope; proteome; adaptive immunity; antigen antibody complex; antigen presenting cell; article; B lymphocyte; binding affinity; bioinformatics; cell surface; cytokine release; enzyme linked immunosorbent assay; human; humoral immunity; immune response; immunogenicity; immunoproteomics; major histocompatibility complex; matrix assisted laser desorption ionization time of flight mass spectrometry; nonhuman; peptide synthesis; polymerase chain reaction; priority journal; protein analysis; protein expression; protein processing; proteomics; T lymphocyte
AbstractThe varied landscape of the adaptive immune response is determined by the peptides presented by immune cells, derived from viral or microbial pathogens or cancerous cells. The study of immune biomarkers or antigens is not new and classical methods such as agglutination, enzyme-linked immunosorbent assay, or Western blotting have been used for many years to study the immune response to vaccination or disease. However, in many of these traditional techniques, protein or peptide identification has often been the bottleneck. Recent advances in genomics and proteomics, has led to many of the rapid advances in proteomics approaches. Immunoproteomics describes a rapidly growing collection of approaches that have the common goal of identifying and measuring antigenic peptides or proteins. This includes gel based, array based, mass spectrometry, DNA based, or in silico approaches. Immunoproteomics is yielding an understanding of disease and disease progression, vaccine candidates, and biomarkers. This review gives an overview of immunoproteomics and closely related technologies that are used to define the full set of antigens targeted by the immune system during disease. © 2013 Springer Science+Business Media, LLC.
Publication date
AffiliationNational Research Council Canada (NRC-CNRC); Human Health Therapeutics (HHT-TSH)
Peer reviewedYes
NPARC number21269644
Export citationExport as RIS
Report a correctionReport a correction
Record identifier83960f9c-4866-48c7-9188-e15dacb27b90
Record created2013-12-13
Record modified2016-05-09
Bookmark and share
  • Share this page with Facebook (Opens in a new window)
  • Share this page with Twitter (Opens in a new window)
  • Share this page with Google+ (Opens in a new window)
  • Share this page with Delicious (Opens in a new window)